The argument with no bid, is that the product appears to work well with a number of different drugs and is very safe. This is worth money to a number of drug companies, we are selling to one. If we licenced the product after approval I believe the revenue would be worth a far higher valuation.
- Forums
- ASX - By Stock
- VLA
- Very Disappointed
Very Disappointed, page-33
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online